Pardes Biosciences Inc. (PRDS)
NASDAQ: PRDS
· Real-Time Price · USD
2.18
0.02 (0.93%)
At close: Aug 30, 2023, 9:59 PM
Pardes Biosciences Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 100.27M | 47.16M | 59.28M | 209.06M | 228.6M | 247.92M | 268.68M | 26.38M | 353.35K | 8.8K |
Short-Term Investments | 52.93M | 125.07M | 138.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 201.26M | n/a |
Other Long-Term Assets | n/a | n/a | 219K | n/a | n/a | n/a | n/a | 1.52M | n/a | 82.9K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 4.11M | 3.91M | 3.06M | 4.99M | 5.25M | 7.22M | 6.58M | 676K | 636.43K | n/a |
Total Current Assets | 157.31M | 176.15M | 200.4M | 214.04M | 233.85M | 255.14M | 275.26M | 27.06M | 989.77K | 8.8K |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | n/a | n/a | 219K | n/a | n/a | n/a | n/a | 1.52M | 201.26M | 82.9K |
Total Assets | 157.31M | 176.15M | 200.62M | 214.04M | 233.85M | 255.14M | 275.26M | 28.58M | 202.25M | 91.7K |
Account Payables | 14K | 3.71M | 4.93M | 1.57M | 1.68M | 2.37M | 2.38M | 2.75M | 142.07K | 1.03K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 1.91M | 7.7M | 15.5M | 10.46M | 9.54M | 6.4M | 6.58M | 3.22M | 1.55M | 66.7K |
Total Current Liabilities | 1.93M | 11.41M | 20.43M | 12.03M | 11.22M | 8.76M | 8.96M | 5.97M | 1.69M | 67.73K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 59.13M | 7.04M | n/a |
Total Long-Term Liabilities | n/a | 3.71M | 4.93M | 1.57M | 1.68M | n/a | n/a | 59.13M | 7.04M | n/a |
Total Liabilities | 1.93M | 11.41M | 20.43M | 12.03M | 11.22M | 8.76M | 8.96M | 65.1M | 8.74M | 67.73K |
Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock | 6K | 6K | 6K | 6K | 6K | 6K | 6K | n/a | 188.51M | 503.00 |
Retained Earnings | -176.74M | -165.96M | -148.16M | -123.94M | -100.6M | -72.96M | -51.52M | -37.18M | -2.34M | -1.03K |
Comprehensive Income | 9K | -23K | -24K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 155.38M | 164.73M | 180.2M | 202.01M | 222.63M | 246.38M | 266.29M | -36.52M | 5M | 23.97K |
Total Investments | 52.93M | 125.07M | 138.06M | n/a | n/a | n/a | n/a | n/a | 201.26M | n/a |